Global Antiandrogen Monotherapy Sales Market Report 2016

Publisher Name :
Date: 12-Sep-2016
No. of pages: 122
Inquire Before Buying

Notes:

Sales, means the sales volume of Antiandrogen Monotherapy

Revenue, means the sales value of Antiandrogen Monotherapy

This report studies sales (consumption) of Antiandrogen Monotherapy in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

- Pfizer Inc. (USA)

- Abbott Laboratories (USA)

- Genentech Inc. (USA)

- GlaxoSmithKline Plc (UK)

- Immunomedics, Inc. (USA)

- Indevus Pharmaceuticals Inc. (USA)

- Novartis AG (Switzerland)

- OSI Pharmaceuticals, Inc. (USA)

- Paladin Labs Inc. (Canada)

- ALZA Corporation (USA)

- Amgen Inc. (USA)

- AstraZeneca PLC (UK)

- Medimmune, LLC (USA)

- Bristol-Myers Squibb Company (USA)

- Cell Genesys Inc. (USA)

- Dendreon Corporation (USA)

- EUSA Pharma, (USA) Inc. (USA)

- F. Hoffmann-La Roche Ltd. (Switzerland)

- Progenics Pharmaceuticals, Inc. (USA)

- Sanofi-Aventis SA (France)

- Spectrum Pharmaceuticals, Inc. (USA)

- Takeda Pharmaceutical Company Limited (Japan)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Antiandrogen Monotherapy in these regions, from 2011 to 2021 (forecast), like

- USA

- China

- Europe

- Japan

- India

- Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Antiandrogen Monotherapy in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Antiandrogen Monotherapy Sales Market Report 2016

Table of Contents
Global Antiandrogen Monotherapy Sales Market Report 2016
1 Antiandrogen Monotherapy Overview
1.1 Product Overview and Scope of Antiandrogen Monotherapy
1.2 Classification of Antiandrogen Monotherapy
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Antiandrogen Monotherapy
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Antiandrogen Monotherapy Market by Regions
1.4.1 USA Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Antiandrogen Monotherapy (2011-2021)
1.5.1 Global Antiandrogen Monotherapy Sales and Growth Rate (2011-2021)
1.5.2 Global Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
2 Global Antiandrogen Monotherapy Competition by Manufacturers, Type and Application
2.1 Global Antiandrogen Monotherapy Market Competition by Manufacturers
2.1.1 Global Antiandrogen Monotherapy Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Antiandrogen Monotherapy Revenue and Share by Manufacturers (2011-2016)
2.2 Global Antiandrogen Monotherapy (Volume and Value) by Type
2.2.1 Global Antiandrogen Monotherapy Sales and Market Share by Type (2011-2016)
2.2.2 Global Antiandrogen Monotherapy Revenue and Market Share by Type (2011-2016)
2.3 Global Antiandrogen Monotherapy (Volume and Value) by Regions
2.3.1 Global Antiandrogen Monotherapy Sales and Market Share by Regions (2011-2016)
2.3.2 Global Antiandrogen Monotherapy Revenue and Market Share by Regions (2011-2016)
2.4 Global Antiandrogen Monotherapy (Volume) by Application
3 USA Antiandrogen Monotherapy (Volume, Value and Sales Price)
3.1 USA Antiandrogen Monotherapy Sales and Value (2011-2016)
3.1.1 USA Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
3.1.2 USA Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
3.1.3 USA Antiandrogen Monotherapy Sales Price Trend (2011-2016)
3.2 USA Antiandrogen Monotherapy Sales and Market Share by Manufacturers
3.3 USA Antiandrogen Monotherapy Sales and Market Share by Type
3.4 USA Antiandrogen Monotherapy Sales and Market Share by Application
4 China Antiandrogen Monotherapy (Volume, Value and Sales Price)
4.1 China Antiandrogen Monotherapy Sales and Value (2011-2016)
4.1.1 China Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
4.1.2 China Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
4.1.3 China Antiandrogen Monotherapy Sales Price Trend (2011-2016)
4.2 China Antiandrogen Monotherapy Sales and Market Share by Manufacturers
4.3 China Antiandrogen Monotherapy Sales and Market Share by Type
4.4 China Antiandrogen Monotherapy Sales and Market Share by Application
5 Europe Antiandrogen Monotherapy (Volume, Value and Sales Price)
5.1 Europe Antiandrogen Monotherapy Sales and Value (2011-2016)
5.1.1 Europe Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
5.1.2 Europe Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
5.1.3 Europe Antiandrogen Monotherapy Sales Price Trend (2011-2016)
5.2 Europe Antiandrogen Monotherapy Sales and Market Share by Manufacturers
5.3 Europe Antiandrogen Monotherapy Sales and Market Share by Type
5.4 Europe Antiandrogen Monotherapy Sales and Market Share by Application
6 Japan Antiandrogen Monotherapy (Volume, Value and Sales Price)
6.1 Japan Antiandrogen Monotherapy Sales and Value (2011-2016)
6.1.1 Japan Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
6.1.2 Japan Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
6.1.3 Japan Antiandrogen Monotherapy Sales Price Trend (2011-2016)
6.2 Japan Antiandrogen Monotherapy Sales and Market Share by Manufacturers
6.3 Japan Antiandrogen Monotherapy Sales and Market Share by Type
6.4 Japan Antiandrogen Monotherapy Sales and Market Share by Application
7 India Antiandrogen Monotherapy (Volume, Value and Sales Price)
7.1 India Antiandrogen Monotherapy Sales and Value (2011-2016)
7.1.1 India Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
7.1.2 India Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
7.1.3 India Antiandrogen Monotherapy Sales Price Trend (2011-2016)
7.2 India Antiandrogen Monotherapy Sales and Market Share by Manufacturers
7.3 India Antiandrogen Monotherapy Sales and Market Share by Type
7.4 India Antiandrogen Monotherapy Sales and Market Share by Application
8 Southeast Asia Antiandrogen Monotherapy (Volume, Value and Sales Price)
8.1 Southeast Asia Antiandrogen Monotherapy Sales and Value (2011-2016)
8.1.1 Southeast Asia Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
8.1.2 Southeast Asia Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
8.1.3 Southeast Asia Antiandrogen Monotherapy Sales Price Trend (2011-2016)
8.2 Southeast Asia Antiandrogen Monotherapy Sales and Market Share by Manufacturers
8.3 Southeast Asia Antiandrogen Monotherapy Sales and Market Share by Type
8.4 Southeast Asia Antiandrogen Monotherapy Sales and Market Share by Application
9 Global Antiandrogen Monotherapy Manufacturers Analysis
9.1 Pfizer Inc. (USA)
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Antiandrogen Monotherapy Product Type, Application and Specification
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 Pfizer Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Abbott Laboratories (USA)
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 122 Product Type, Application and Specification
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 Abbott Laboratories (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 Genentech Inc. (USA)
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 142 Product Type, Application and Specification
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 Genentech Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline Plc (UK)
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Aug Product Type, Application and Specification
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Immunomedics, Inc. (USA)
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Product Type, Application and Specification
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 Immunomedics, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 Indevus Pharmaceuticals Inc. (USA)
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Million USD Product Type, Application and Specification
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 Novartis AG (Switzerland)
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharma & Healthcare Product Type, Application and Specification
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 Novartis AG (Switzerland) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 OSI Pharmaceuticals, Inc. (USA)
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Product Type, Application and Specification
9.8.2.1 Type I
9.8.2.2 Type II
9.8.3 OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 Paladin Labs Inc. (Canada)
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Product Type, Application and Specification
9.9.2.1 Type I
9.9.2.2 Type II
9.9.3 Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 ALZA Corporation (USA)
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Product Type, Application and Specification
9.10.2.1 Type I
9.10.2.2 Type II
9.10.3 ALZA Corporation (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview
9.11 Amgen Inc. (USA)
9.12 AstraZeneca PLC (UK)
9.13 Medimmune, LLC (USA)
9.14 Bristol-Myers Squibb Company (USA)
9.15 Cell Genesys Inc. (USA)
9.16 Dendreon Corporation (USA)
9.17 EUSA Pharma, (USA) Inc. (USA)
9.18 F. Hoffmann-La Roche Ltd. (Switzerland)
9.19 Progenics Pharmaceuticals, Inc. (USA)
9.20 Sanofi-Aventis SA (France)
9.21 Spectrum Pharmaceuticals, Inc. (USA)
9.22 Takeda Pharmaceutical Company Limited (Japan)
10 Antiandrogen Monotherapy Maufacturing Cost Analysis
10.1 Antiandrogen Monotherapy Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Antiandrogen Monotherapy
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Antiandrogen Monotherapy Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Antiandrogen Monotherapy Market Forecast (2016-2021)
14.1 Global Antiandrogen Monotherapy Sales, Revenue Forecast (2016-2021)
14.2 Global Antiandrogen Monotherapy Sales Forecast by Regions (2016-2021)
14.3 Global Antiandrogen Monotherapy Sales Forecast by Type (2016-2021)
14.4 Global Antiandrogen Monotherapy Sales Forecast by Application (2016-2021)
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Antiandrogen Monotherapy
Table Classification of Antiandrogen Monotherapy
Figure Global Sales Market Share of Antiandrogen Monotherapy by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Antiandrogen Monotherapy
Figure Global Sales Market Share of Antiandrogen Monotherapy by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Figure China Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Figure Europe Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Figure Japan Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Figure India Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Figure Global Antiandrogen Monotherapy Sales and Growth Rate (2011-2021)
Figure Global Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Table Global Antiandrogen Monotherapy Sales of Key Manufacturers (2011-2016)
Table Global Antiandrogen Monotherapy Sales Share by Manufacturers (2011-2016)
Figure 2015 Antiandrogen Monotherapy Sales Share by Manufacturers
Figure 2016 Antiandrogen Monotherapy Sales Share by Manufacturers
Table Global Antiandrogen Monotherapy Revenue by Manufacturers (2011-2016)
Table Global Antiandrogen Monotherapy Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Antiandrogen Monotherapy Revenue Share by Manufacturers
Table 2016 Global Antiandrogen Monotherapy Revenue Share by Manufacturers
Table Global Antiandrogen Monotherapy Sales and Market Share by Type (2011-2016)
Table Global Antiandrogen Monotherapy Sales Share by Type (2011-2016)
Figure Sales Market Share of Antiandrogen Monotherapy by Type (2011-2016)
Figure Global Antiandrogen Monotherapy Sales Growth Rate by Type (2011-2016)
Table Global Antiandrogen Monotherapy Revenue and Market Share by Type (2011-2016)
Table Global Antiandrogen Monotherapy Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antiandrogen Monotherapy by Type (2011-2016)
Figure Global Antiandrogen Monotherapy Revenue Growth Rate by Type (2011-2016)
Table Global Antiandrogen Monotherapy Sales and Market Share by Regions (2011-2016)
Table Global Antiandrogen Monotherapy Sales Share by Regions (2011-2016)
Figure Sales Market Share of Antiandrogen Monotherapy by Regions (2011-2016)
Figure Global Antiandrogen Monotherapy Sales Growth Rate by Regions (2011-2016)
Table Global Antiandrogen Monotherapy Revenue and Market Share by Regions (2011-2016)
Table Global Antiandrogen Monotherapy Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Antiandrogen Monotherapy by Regions (2011-2016)
Figure Global Antiandrogen Monotherapy Revenue Growth Rate by Regions (2011-2016)
Table Global Antiandrogen Monotherapy Sales and Market Share by Application (2011-2016)
Table Global Antiandrogen Monotherapy Sales Share by Application (2011-2016)
Figure Sales Market Share of Antiandrogen Monotherapy by Application (2011-2016)
Figure Global Antiandrogen Monotherapy Sales Growth Rate by Application (2011-2016)
Figure USA Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
Figure USA Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
Figure USA Antiandrogen Monotherapy Sales Price Trend (2011-2016)
Table USA Antiandrogen Monotherapy Sales by Manufacturers (2011-2016)
Table USA Antiandrogen Monotherapy Market Share by Manufacturers (2011-2016)
Table USA Antiandrogen Monotherapy Sales by Type (2011-2016)
Table USA Antiandrogen Monotherapy Market Share by Type (2011-2016)
Table USA Antiandrogen Monotherapy Sales by Application (2011-2016)
Table USA Antiandrogen Monotherapy Market Share by Application (2011-2016)
Figure China Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
Figure China Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
Figure China Antiandrogen Monotherapy Sales Price Trend (2011-2016)
Table China Antiandrogen Monotherapy Sales by Manufacturers (2011-2016)
Table China Antiandrogen Monotherapy Market Share by Manufacturers (2011-2016)
Table China Antiandrogen Monotherapy Sales by Type (2011-2016)
Table China Antiandrogen Monotherapy Market Share by Type (2011-2016)
Table China Antiandrogen Monotherapy Sales by Application (2011-2016)
Table China Antiandrogen Monotherapy Market Share by Application (2011-2016)
Figure Europe Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
Figure Europe Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
Figure Europe Antiandrogen Monotherapy Sales Price Trend (2011-2016)
Table Europe Antiandrogen Monotherapy Sales by Manufacturers (2011-2016)
Table Europe Antiandrogen Monotherapy Market Share by Manufacturers (2011-2016)
Table Europe Antiandrogen Monotherapy Sales by Type (2011-2016)
Table Europe Antiandrogen Monotherapy Market Share by Type (2011-2016)
Table Europe Antiandrogen Monotherapy Sales by Application (2011-2016)
Table Europe Antiandrogen Monotherapy Market Share by Application (2011-2016)
Figure Japan Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
Figure Japan Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
Figure Japan Antiandrogen Monotherapy Sales Price Trend (2011-2016)
Table Japan Antiandrogen Monotherapy Sales by Manufacturers (2011-2016)
Table Japan Antiandrogen Monotherapy Market Share by Manufacturers (2011-2016)
Table Japan Antiandrogen Monotherapy Sales by Type (2011-2016)
Table Japan Antiandrogen Monotherapy Market Share by Type (2011-2016)
Table Japan Antiandrogen Monotherapy Sales by Application (2011-2016)
Table Japan Antiandrogen Monotherapy Market Share by Application (2011-2016)
Figure India Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
Figure India Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
Figure India Antiandrogen Monotherapy Sales Price Trend (2011-2016)
Table India Antiandrogen Monotherapy Sales by Manufacturers (2011-2016)
Table India Antiandrogen Monotherapy Market Share by Manufacturers (2011-2016)
Table India Antiandrogen Monotherapy Sales by Type (2011-2016)
Table India Antiandrogen Monotherapy Market Share by Type (2011-2016)
Table India Antiandrogen Monotherapy Sales by Application (2011-2016)
Table India Antiandrogen Monotherapy Market Share by Application (2011-2016)
Figure Southeast Asia Antiandrogen Monotherapy Sales and Growth Rate (2011-2016)
Figure Southeast Asia Antiandrogen Monotherapy Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Antiandrogen Monotherapy Sales Price Trend (2011-2016)
Table Southeast Asia Antiandrogen Monotherapy Sales by Manufacturers (2011-2016)
Table Southeast Asia Antiandrogen Monotherapy Market Share by Manufacturers (2011-2016)
Table Southeast Asia Antiandrogen Monotherapy Sales by Type (2011-2016)
Table Southeast Asia Antiandrogen Monotherapy Market Share by Type (2011-2016)
Table Southeast Asia Antiandrogen Monotherapy Sales by Application (2011-2016)
Table Southeast Asia Antiandrogen Monotherapy Market Share by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Genentech Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Immunomedics, Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG (Switzerland) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information List
Table ALZA Corporation (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure ALZA Corporation (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Amgen Inc. (USA) Basic Information List
Table Amgen Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table AstraZeneca PLC (UK) Basic Information List
Table AstraZeneca PLC (UK) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca PLC (UK) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Medimmune, LLC (USA) Basic Information List
Table Medimmune, LLC (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Medimmune, LLC (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Bristol-Myers Squibb Company (USA) Basic Information List
Table Bristol-Myers Squibb Company (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Company (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Cell Genesys Inc. (USA) Basic Information List
Table Cell Genesys Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Cell Genesys Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Dendreon Corporation (USA) Basic Information List
Table Dendreon Corporation (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dendreon Corporation (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Basic Information List
Table EUSA Pharma, (USA) Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure EUSA Pharma, (USA) Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List
Table Progenics Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Progenics Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Sanofi-Aventis SA (France) Basic Information List
Table Sanofi-Aventis SA (France) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi-Aventis SA (France) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List
Table Spectrum Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Spectrum Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceutical Company Limited (Japan) Antiandrogen Monotherapy Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiandrogen Monotherapy
Figure Manufacturing Process Analysis of Antiandrogen Monotherapy
Figure Antiandrogen Monotherapy Industrial Chain Analysis
Table Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2015
Table Major Buyers of Antiandrogen Monotherapy
Table Distributors/Traders List
Figure Global Antiandrogen Monotherapy Sales and Growth Rate Forecast (2016-2021)
Figure Global Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2016-2021)
Table Global Antiandrogen Monotherapy Sales Forecast by Regions (2016-2021)
Table Global Antiandrogen Monotherapy Sales Forecast by Type (2016-2021)
Table Global Antiandrogen Monotherapy Sales Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Global Compounding Pharmacy Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 25-May-2017        Price: US 3480 Onwards        Pages: 116
    The traditional role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs. For example: A young child may need a small, liquid dose of a drug made only in adult-dosage tablets. A person may be allergic to one of the ingredients in the commercial version of a drug. A compounding pharmacy would make the proper dosage and form of the drug without any offending ......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 127
    In this report, the global Foot and Mouth Disease (FMD) Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Foot and Mouth Disease (FMD) Vaccines in these regions, from 2012 to 2022 (forecast), covering - North America......
  • Global Tourniquet Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Tourniquet market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Tourniquet in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan ......
  • 2017-2022 China Liquid Biopsy Products Market Report (Status and Outlook)
    Published: 24-May-2017        Price: US 3360 Onwards        Pages: 119
    "This report will be delivered in 2-3 business days after the order is placed." The Liquid Biopsy Products market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include - RainDanceTechnologies - Biocartis - Qiagen - Guardant Health - MDxHealth - Pathway Genomics - NeoGe......
  • Global Solid Organ Transplant Immunosuppressant Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 109
    In this report, the global Solid Organ Transplant Immunosuppressant market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Solid Organ Transplant Immunosuppressant in these regions, from 2012 to 2022 (forecast), covering - North A......
  • Global Sufentanil (API) Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 102
    In this report, the global Sufentanil (API) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Sufentanil (API) in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - J......
  • Global Communicable Diseases Treatment Market Size, Status and Forecast 2022
    Published: 24-May-2017        Price: US 3300 Onwards        Pages: 106
    This report studies the global Communicable Diseases Treatment market, analyzes and researches the Communicable Diseases Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Bristol-Myers Squibb Pharmaceutical - Eli Lilly - GlaxoSmithKline - Johnson & Johnson - Medtronic - Merck - Pfizer - F. Hoffmann-La Roche - Sanofi......
  • Global Companion Animal Speciality Drugs Market Size, Status and Forecast 2022
    Published: 24-May-2017        Price: US 3300 Onwards        Pages: 101
    This report studies the global Companion Animal Speciality Drugs market, analyzes and researches the Companion Animal Speciality Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Zoetis - Merck - Merial - Elanco - Bayer Animal Health - Boehringer Ingelheim Vetmedica - Virbac - Ceva Sante Animale - Vétoquinol - Juro......
  • 2017-2022 India Liquid Biopsy Products Market Report (Status and Outlook)
    Published: 24-May-2017        Price: US 3360 Onwards        Pages: 119
    "This report will be delivered in 2-3 business days after the order is placed." The Liquid Biopsy Products market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In India market, the top players include - RainDanceTechnologies - Biocartis - Qiagen - Guardant Health - MDxHealth - Pathway Genomics - NeoGe......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs